STEAP1 Suppresses Oral Squamous Cell Carcinoma by Targeting Wnt/β‐Catenin Signalling and EMT

Documenti analoghi

• Elevated KIF2C Expression Drives Osteosarcoma Progression by Modulating the Wnt/β‐Catenin Signaling Pathway and Contributing to an Immunosuppressive Tumor Microenvironment
  di: Ya‐Yun Liu, et al.
  Pubblicazione: (2025)
• Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma
  di: Shin Tojo, et al.
  Pubblicazione: (2024)
• Camrelizumab Plus Famitinib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Study
  di: Bei Xu, et al.
  Pubblicazione: (2026)
• Correction to ‘ MUC1 as a Target for CAR ‐T Therapy in Head and Neck Squamous Cell Carcinoma’
  Pubblicazione: (2024)
• HLA‐DQB1*05:02: A Novel Genetic Marker for Susceptibility to Oral Cavity Squamous Cell Carcinoma
  di: Shiang‐Fu Huang, et al.
  Pubblicazione: (2025)